Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
12/2007
12/04/2007CA2157506C Osteogenic growth oligopeptides and pharmaceutical compositions containing them
11/2007
11/29/2007WO2007137080A2 Compounds and compositions as channel activating protease inhibitors
11/29/2007WO2007136635A1 Enhancement of radiation therapy and/or chemotherapy with acid ceramidase modulators
11/29/2007WO2007136294A1 Peptide substance enhancing capillaries resistance, pharmaceutical composition on its base and method of its application
11/29/2007WO2007112345A3 Use of cyclosporin alkene analogues for preventing or treating viral-induced disorders
11/29/2007US20070275906 Compounds and Compositions as Channel Activating Protease Inhibitors
11/29/2007US20070275904 Conjugates of aziridinyl-epothilone analogs and pharmaceutical compositions comprising same
11/29/2007US20070275903 oligopeptide conjugates; cleavable by trouase such as Thimet oligopeptidase; antitumor agents
11/29/2007US20070275901 Synthesis, modification and reduction of primary structure of hypotensive peptides present in scorpion venom for optimizing their use as a hypotensive medicament
11/29/2007US20070275900 HIV protease inhibitory compounds with ameliorated solubility and/or bioavailability; conjugates of therapeutic compound and a peptide wherein the conjugate is cleavable by dipeptidyl-peptidases
11/29/2007US20070275420 Method For Detecting Prognosis Of Cancer
11/29/2007CA2651762A1 Compounds and compositions as channel activating protease inhibitors
11/28/2007EP1858913A2 Mimetic peptides and the use thereof in the form of 20s, 26s and immunoproteasome inhibitors
11/28/2007EP1858912A2 Compounds for reducing aggregation of amyloid beta-peptide
11/28/2007CN101080418A Tripeptide and tetrapeptide sulfones
11/28/2007CN101077875A Boronic ester and acid compounds, synthesis and uses
11/27/2007US7301041 Bi-functional metallocenes, preparation process and use in the labeling or biological molecules
11/27/2007US7301005 Immunomodulatory peptides derived from heat shock proteins and uses thereof
11/27/2007US7300663 Adhesion and sealing of tissue with compositions containing polyfunctional crosslinking agents and protein polymers
11/22/2007WO2007133865A2 Hcv/hiv inhibitors an their uses
11/22/2007WO2007132277A1 New pharmaceutical intermediates in the synthesis of ace- inhibitors and the use thereof
11/22/2007WO2007132054A1 New use of therapeutically useful peptides
11/22/2007WO2007131966A1 Macrocyclic compounds as antiviral agents
11/22/2007WO2007087572A3 Aza-peptide epoxides
11/22/2007WO2007076322A3 Compositions and methods for attenuating mitochondria-mediated cell injury
11/22/2007WO2003041483A3 Method to study and mechanisms of biofilm-related antibiotic resistance
11/22/2007US20070270480 Biphenyl Derived Thiamides as Calpain Inhibitors
11/22/2007US20070270349 Glutathione Derivatives and Their Uses for the Treatment of Viral Diseases
11/22/2007US20070269832 Novel affinity labels
11/22/2007US20070269450 Biologically active peptides
11/22/2007CA2652388A1 New use of therapeutically useful peptides
11/22/2007CA2652219A1 Macrocyclic compounds as antiviral agents
11/22/2007CA2643680A1 Hcv/hiv inhibitors and their uses
11/21/2007EP1857463A1 Peptide having neuroprotective effects
11/21/2007EP1857462A1 Polyoxyalkylene derivative
11/21/2007EP1619201B1 Novel glycopeptide or peptide capable of imparting rich taste and method of imparting rich taste to food therewith
11/21/2007EP1150996B1 New amidinobenzylamine derivatives and their use as thrombin inhibitors
11/21/2007EP0871463B2 Regulation of eating behavior
11/21/2007EP0842196B1 Cell adhesion inhibitors
11/21/2007EP0529031B9 Improved inhibitors of thrombin
11/21/2007CN101076516A Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease
11/21/2007CN101076515A Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives
11/21/2007CN101073668A Antibody compositions for selectively inhibiting vegf
11/20/2007US7297784 Genetic enhancers comprising amino acid sequences derived from retrovirus envelope proteins coupled to core peptides, used as drugs having improve half life
11/20/2007US7297761 Pharmaceutical compositions containing exendins
11/20/2007US7297760 Cancer associated protein
11/20/2007US7297701 Anti-cancer cyclopenta [G]quinazoline compounds
11/20/2007US7297681 For use in therapy of growth metabolic disorders
11/20/2007CA2192455C Positive and positive/negative cell selection mediated by peptide release
11/15/2007WO2007131034A1 Pyrimidone derivatives which are modulators of heat shock protein (hsp) 70
11/15/2007WO2007129952A1 Novel peptide derivatives useful as antimicrobial agents for treating wounds
11/15/2007WO2007128493A1 Neuroprotective compounds and uses thereof
11/15/2007WO2007053792A3 Improving the pharmacokinetics of protease inhibitors and other drugs
11/15/2007WO2005120564A3 Vaccine compositions and methods
11/15/2007WO2002068586A3 Hiv/fiv protease inhibitors
11/15/2007US20070265331 Such as (2S)-2-(3(S)-Acetylamino-3-((S)-sec-butyl)-2-oxo-pyrrolidin-1-yl)-N-[(1S,2R)-1-(3,5-difluoro-benzyl)-2-hydroxy-3-(3-methoxy-benzylamino)-propyl]-4-phenyl-butyramide; inhibit processing of amyloid precursor proteins
11/15/2007US20070265248 Substituted piperazines and methods of use
11/15/2007US20070265244 2-[1-(1-carboxymethyl-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-3-ylcarbamoyl)-cyclopentylmethyl]-N-(3-dimethylamino-propyl)-N-methyl-succinamic acid, or a biolabile ester thereof; neutral endopeptidase and/or human soluble endopeptidase (hSEP) inhibitors; cardiovascular diseases, apoptosis e.g. stroke
11/15/2007US20070265212 Drug Transport and Delivery System
11/14/2007EP1854807A1 Polyoxyalkylene chain-containing lipid derivative and lipid film structure containing such derivative
11/14/2007EP1853626A2 Amyloid-binding peptides, analogues and uses thereof
11/14/2007EP1853603A1 Peptidomimetic compounds and preparation of biologically active derivatives
11/14/2007EP1654261B1 Hepatitis c inhibitor compounds
11/14/2007EP1585541B1 Pharmaceutical compositions comprising insulin and legends of insulin hexamer
11/14/2007CN100348612C Peptide benzamide compound and its preparation method
11/13/2007US7294622 Lactams and uses thereof
11/13/2007US7294615 Compounds that associate on the intermolecular level and aggregate bodies that contain them
11/08/2007WO2007125946A1 Peptide
11/08/2007WO2007125203A1 Gem-difluoride c-glycopeptide compounds, their preparation and use particularly for preservation of biological materials.
11/08/2007WO2007124770A1 Cosmetic composition for stimulating the synthesis of proteins of the basement membrane
11/08/2007WO2007109118A3 RECOMBINANT HUMAN CC 10 (rhCC10) FOR TREATMENT OF RESPIRATORY DISORDERS
11/08/2007WO2007011601A3 Cancer treatment using viruses, fluoropyrimidines and camptothecins
11/08/2007WO2007004876A3 Peptides inhibiting angiotensin-converting enzyme
11/08/2007WO2002012270A9 Peptides capable of functioning as mimotopes for estradiol analytes
11/08/2007US20070260039 Methods of Producing Silk Polypeptides and Products Thereof
11/08/2007US20070259820 Methods and reagents for activating heat shock protein 70
11/08/2007US20070259812 Peptide deformylase inhibitors as novel antibiotics
11/08/2007US20070258947 Depeptidized Inhibitors of Hepatitis C Virus NS3 Protease
11/08/2007CA2650578A1 Cosmetic composition for stimulating the synthesis of proteins of the basement membrane
11/08/2007CA2649993A1 Gem-difluoride c-glycopeptide compounds, their preparation and use particularly for preservation of biological materials.
11/08/2007CA2647260A1 Solid support reagents for synthesis
11/07/2007EP1852020A1 Sweetener composition improved in taste, its use and process for preparing it
11/07/2007EP1042288B1 Tripeptidyl peptidase inhibitors
11/07/2007CN101068828A Acylsulfonamide compounds as inhibitors of hepatitis c virus NS3 serine protease
11/07/2007CN101066989A Process of separating and purifying glutathione from fermented liquid in a four-area simulated moving bed
11/06/2007US7291710 Detection of spectrin and spectrin proteolytic cleavage products in assessing nerve cell damage
11/01/2007WO2007122199A1 Synthesis and uses of pyroglutamic acid derivatives
11/01/2007WO2007043048A3 Self-assembled fmoc-ff hydrogels
11/01/2007WO2002064619A3 Peptides that inhibit poly-glutamine aggregation
11/01/2007US20070254846 stimulating T-cell transformation; cell proliferative disorder, anti-cancer, and/or anti-sarcoma
11/01/2007US20070253967 Agent for the treatment and/or prophylaxis of microcirculatory disorders
11/01/2007CA2649762A1 Synthesis and uses of pyroglutamic acid derivatives
10/2007
10/31/2007EP1849797A2 Peptidomimetic protease inhibitors
10/31/2007EP1011707B1 HIV-1 gp120 V1/V2 DOMAIN EPITOPES CAPABLE OF GENERATING NEUTRALIZING ANTIBODIES
10/31/2007CN101062938A Preparation method of N(2)-L-alanyl-L-glutamine
10/31/2007CN100345866C Compound for unstable dipeptidyl peptidase IV inhibitors
10/31/2007CN100345865C Antibiotic dipeptide and its chemical modifier, its preparation method and uses
10/30/2007US7288670 Synthesis of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester using 3,3-dimethylbutyraldehyde precursors
10/30/2007US7288661 Coupling, hydrogenation, catalysis; reacting benzyl indole-2-carboxylate with acid and alanine compound; amidation, salt formation
10/30/2007US7288624 Treating IL-1 mediated disease, autoimmune disease, inflammatory disease and neurodegenerative disease with ICE inhibitors characterized by specific structural and physicochemical features.
1 ... 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 ... 307